Trials / Completed
CompletedNCT05226286
Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2)
Evaluation of Implantable Tibial Neuromodulation Pivotal Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 188 (actual)
- Sponsor
- MedtronicNeuro · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this prospective, multicenter study is to assess the safety and efficacy of tibial neuromodulation using the Medtronic Tibial Neuromodulation (TNM) system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Medtronic Implantable Tibial Neuromodulation (TNM) System | Stimulation of the tibial nerve using Medtronic's tibial neuromodulation device. |
Timeline
- Start date
- 2022-01-31
- Primary completion
- 2023-10-10
- Completion
- 2025-05-30
- First posted
- 2022-02-07
- Last updated
- 2025-11-21
- Results posted
- 2025-11-21
Locations
29 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05226286. Inclusion in this directory is not an endorsement.